BDBM557872 1-(4-((4-((4-bromo-3- chlorophenyl)amino)-7- methoxyquinazolin-6-yl)- oxy)piperidin-1-yl)prop-2- en-1-one::US11365189, Ex. No. 37

SMILES COc1cc2ncnc(Nc3ccc(Br)c(Cl)c3)c2cc1OC1CCN(CC1)C(=O)C=C

InChI Key InChIKey=DFVDVYUOEWJKHR-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 557872   

TargetReceptor tyrosine-protein kinase erbB-2 [1-775,'YVMA',776-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 30nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [1-780,'GSP',781-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 11nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 23nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 21nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [S768I](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 5nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'SVD',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 29nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'NPG',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 20nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SVD',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 39nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SV',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557872(US11365189, Ex. No. 37 | 1-(4-((4-((4-bromo-3- chl...)
Affinity DataIC50: 21nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent